Try our Advanced Search for more refined results
MERCK & CO., INC. et al v. UNITED STATES DEPARTMENT OF HEALTH AND HUMAN SERVICES et al
Case Number:
1:19-cv-01738
Court:
Nature of Suit:
Judge:
Firms
Companies
Government Agencies
Sectors & Industries:
-
August 21, 2019
Feds Look To DC Circ. To Revive Drug Pricing Rule
The U.S. Department of Health and Human Services looked to the D.C. Circuit Wednesday hoping to overturn a federal judge's July decision vacating a federal regulation that would have mandated the disclosure of wholesale drug prices in television advertisements.
-
July 10, 2019
3 Takeaways From Nixing Of Drug Pricing Rule
The day before it was scheduled to go into effect, a D.C. federal judge struck down a Trump administration rule requiring drug prices to be disclosed in TV ads, a new regulation that could have amped up U.S. Department of Health and Human Services' regulatory power.
-
July 08, 2019
Judge Nixes Rule Forcing Drug Prices In TV Ads
A D.C. federal judge on Monday vacated a federal regulation mandating the disclosure of wholesale drug prices in television advertisements, a decision that came just the day before the controversial requirement was set to take effect.
-
July 02, 2019
Feds, Drugmakers Grilled Over Rule Mandating Prices In Ads
A D.C. federal judge asked sharp questions Tuesday as to whether the government can require manufacturers' drug prices in TV ads, as several drugmakers argued that a new rule mandating the disclosures would mislead consumers and step outside the feds' authority.
-
June 18, 2019
Swift Ruling Vowed On Rule Requiring Drug Prices In TV Ads
A D.C. federal judge is expected to decide in less than three weeks — a blazingly quick turnaround — on whether to block a new U.S. Department of Health and Human Services rule requiring drug prices in TV ads as the regulation's effective date looms.
-
June 14, 2019
Pharma Cos. Sue HHS Over Putting Drug Prices In Ads
Merck & Co. Inc., Eli Lilly & Co. and Amgen Inc. on Friday sued the U.S. Department of Health and Human Services over a new rule requiring drugmakers to put the wholesale price of medications in ads, saying the requirement will mislead consumers about how much they'll actually have to pay.